Key result
Moderate MCU overexpression improves fractional shortening ~31% and prevents arrhythmias in heart failure models.
Why the study?
Enhancing mitochondrial Ca2+ can reverse metabolic defects in heart failure but may increase mitochondrial Ca2+ overload, making it unclear whether moderate MCU overexpression is beneficial or detrimental.
Does moderate MCU overexpression improve cardiac function and prevent arrhythmias in a guinea pig model of heart failure?
Does moderate MCU overexpression improve cardiac function and prevent arrhythmias in a guinea pig model of heart failure?
Answers are grounded in this paper and cite their sources.
Moderate MCU overexpression in a guinea pig model of heart failure reverses cardiac dysfunction and inhibits ventricular arrhythmias by reducing mitochondrial oxidative stress-induced SR Ca2+ leak.
Rationale: In heart failure (HF), impaired sarcoplasmic reticulum (SR) Ca 2+ release and cytosolic Na + overload depress mitochondrial Ca 2+ (mCa 2+ ) signaling, resulting in a diminished ability to maintain matrix NAD(P)H redox potential, leading to increased oxidative stress when workload increases. Enhancing mCa 2+ can reverse this defect but could potentially increase the likelihood of mCa 2+ overload. Objective: To determine if moderate mCa 2+ uniporter (MCU) overexpression has beneficial or detrimental effects on the development of HF and incident arrythmias in a guinea pig model (ACi) of HF and sudden cardiac death. Methods and Results: In vivo viral gene transfer was used to increase MCU levels by ≈57% in ACi hearts. Left ventricular myocytes from hearts with MCU overexpression (ACi+MCU) displayed enhanced mCa 2+ uptake, decreased oxidative stress, and increased β-adrenergic- and frequency-dependent augmentation of Ca 2+ transients and contractions, compared with myocytes from ACi hearts. MCU overexpression decreased SR Ca 2+ leak in the ACi group and mitigated the elevated RyR (ryanodine receptor) disulfide crosslinks in HF. β-Adrenergic responses were blunted in isolated perfused ACi hearts, and these deficiencies were normalized in ACi+MCU hearts. To examine the in vivo effects of MCU overexpression, ACi hearts were transduced with the MCU virus 2 to 3 weeks after aortic constriction, at the onset of cardiac decompensation. Two weeks later, cardiac function worsened in the untreated ACi group (fractional shortening: 39±1% at 2 weeks and 32±1% at 4 weeks), whereas MCU overexpression significantly improved cardiac function (36±1% at 2 weeks and 42±2% at 4 weeks). MCU overexpression in the decompensating ACi heart also attenuated pulmonary edema and interstitial fibrosis and prevented triggered arrhythmias. Conclusions: Moderate MCU overexpression in failing hearts enhances contractility and responses to β-adrenergic stimulation in isolated myocytes and perfused hearts by inhibiting mitochondrial oxidative stress-induced SR Ca 2+ leak. MCU overexpression also reversed HF and inhibited ectopic ventricular arrhythmias.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2021) studied Heart failure. MCU overexpression via in vivo viral gene transfer vs. Untreated ACi group was evaluated on Fractional shortening at 4 weeks. Moderate MCU overexpression in a guinea pig heart failure model improved fractional shortening at 4 weeks and prevented triggered arrhythmias.
Synapse has enriched 10 related papers. Consider them for comparative context: